File Download

There are no files associated with this item.

Supplementary

Conference Paper: Targeting STING pathway as a therapeutic strategy against β-catenin driven immune escape and resistance to anti-PD1 therapy in hepatocellular carcinoma

TitleTargeting STING pathway as a therapeutic strategy against β-catenin driven immune escape and resistance to anti-PD1 therapy in hepatocellular carcinoma
Authors
Issue Date10-Aug-2024
Persistent Identifierhttp://hdl.handle.net/10722/354011

 

DC FieldValueLanguage
dc.contributor.authorZhang, Q-
dc.contributor.authorBi, J-
dc.contributor.authorYeung, OWH-
dc.contributor.authorDing, T-
dc.contributor.authorChan, WL-
dc.contributor.authorZhu, Y-
dc.contributor.authorLiu, J-
dc.contributor.authorNg, KTP-
dc.contributor.authorChing, YP-
dc.contributor.authorMan, K-
dc.date.accessioned2025-02-06T00:35:32Z-
dc.date.available2025-02-06T00:35:32Z-
dc.date.issued2024-08-10-
dc.identifier.urihttp://hdl.handle.net/10722/354011-
dc.languageeng-
dc.relation.ispartofInternational Digestive Disease Forum 2024 (10/08/2024-11/08/2024, Hong Kong)-
dc.titleTargeting STING pathway as a therapeutic strategy against β-catenin driven immune escape and resistance to anti-PD1 therapy in hepatocellular carcinoma-
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats